ixa banner2

Hyperimmunized / iABO Pre-Meeting Symposium

11:00-13:00 Part 1: Basic science

  Introductory remarks
Robert Montgomery
Professor, Department of Surgery, Director, NYU Langone Transplant Institute, NY, United States
  Humoral immunity: innate and adaptive responses
Speaker TBD
  B cell biology and transplantation
Anita Chong
Professor, University of Chicago, Chicago, IL, United States
  Innate antibodies and transplantation
Emmanuel Zorn
Adjunct Assistant Professor of Surgery, Columbia University Medical Center, New York, NY, United States
  Antibody-dependent endothelium injury
Elaine Reed
Professor of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, United States
  Immune receptor sequencing to interrogate the B cell repertoire
Eline Luning Prak

University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia, PA, United States

14:00-15:00 Part 2: iABO

  Tolerance across the ABO barrier
Lori West

Professor, University of Alberta, Edmonton, AB, Canada
  Protocols and outcomes of iABO transplants
Kazunari Tanabe

Professor, Tokyo Women's Medical University, Tokyo, Japan
  Accommodation: evidence and mechanisms
Jeffrey Platt

Professor of Surgery and Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States

15:00-17:15 Part 3: Hyperimmunized Patient

  AMR through a classic microscope
Robert Colvin

Pathologist-in-Chief, Emeritus, Massachusetts General Hospital, Boston, MA, United States
  AMR through a molecular microscope
Philip Halloran

Director, Alberta Transplant Applied Genomic Centre, Edmonton, AB, Canada
  HLA and Non-HLA antibodies
Andrea Zachary

Professor Emeritus, Johns Hopkins University School of Medicine, Baltimore, MD, United States
  Quantifying HLA antibody strength
Anat Tambur

HLA Lab Director, Northwestern University, Chicago, IL, United States
  AMR phenotypes and the role of C1q
Alexandre Loupy

Nephrologist, Department of Nephrology and Kidney Transplantation, Necker Hospital, Paris, France
  Options available to the hyper immunized patient
Robert Montgomery

Professor, Department of Surgery, Director, NYU Langone Transplant Institute, NY, United States
  Complement inhibitors
Denis Glotz

Head, Department of nephrology and transplantation, Hopital Saint Louis, Paris, France
  New agents for the prevention and treatment of AMR
Stanley Jordan

Director of Nephrology, Director of HLA and Transplant Immunology Laboratory, Comprehensive Transplant Center, Medical Director of Kidney Transplant Program, Cedar-Sinai Medical Center, Los Angeles, CA, United States
  Clinical trials for the diagnosis, prevention, and treatment of AMR
Speaker TBD

swine header